So far this year, 36 novel drugs have passed muster with the FDA compared to 26 during the same period (Jan- Aug) in 2019. Let's take a look at the companies that await a ruling from the FDA in September.
from RTT - Biotech https://ift.tt/3hsqJBT
via IFTTT
No comments:
Post a Comment